跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ifamso-E - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ifamso-E
Approved
STANDARD
Ifamso-E
Svizera Labs Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
42f2ceb352bc0166
Company
Svizera Labs Private Limited
Type
Standard
Approval Details
Approval Id
42f2ceb352bc0166
Drug Approval Philippines Name
Ifamso-E
Product Name
Ifamso-E
Registration Number
DRP-11051
Brand Name
Ifamso-E
Generic Name
Rifampicin + Isoniazid + Ethambutol Hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
150 mg/ 75 mg/ 275 mg
Manufacturer
Svizera Labs Private Limited
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
25 January 2022
Expiry Date
25 January 2027
Pharmacologic Category
Antituberculosis
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
42f2ceb352bc0166
Type
Standard
Back to Philippines FDA Approvals